We identified actions that Washington has taken, using Federal funds for improving prescription drug monitoring programs (PDMPs), to achieve program goals toward improving safe prescribing practices and preventing prescription drug abuse and misuse. As of July 2018, Washington had completed some of the activities it proposed for the Centers for Disease Control and Prevention (CDC) grant to enhance and maximize its PDMP. Specifically, of the 11 activities proposed for the audit period (March 1, 2016, through August 31, 2017), 6 were completed, and the remaining 5 were partially completed.
Report File
Date Issued
Submitting OIG
Department of Health & Human Services OIG
Other Participating OIGs
Department of Health & Human Services OIG
Agencies Reviewed/Investigated
Department of Health & Human Services
Components
Centers for Disease Control and Prevention
Report Number
A-09-18-01001
Report Description
Report Type
Audit
Agency Wide
Yes
Additional Details